Clinical Trials Browser

Phase 2 × Withdrawn × Cytokine Release Syndrome × Clear all

NCT06352866 2025-03-03

Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Phase 2 Withdrawn

Cytokine Release Syndrome, Multiple Myeloma